What is the evidence for using hydroxyurea for secondary stroke prevention?

Hematology Am Soc Hematol Educ Program. 2011:2011:440-2. doi: 10.1182/asheducation-2011.1.440.

Abstract

A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Blood Transfusion
  • Child
  • Humans
  • Hydroxyurea / therapeutic use*
  • Male
  • Secondary Prevention*
  • Stroke / drug therapy*
  • Stroke / prevention & control*

Substances

  • Hydroxyurea